Π‘ΠΈΠ½ΡΠ΅Π· ΠΈ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΠΈΠ·Π°ΡΠΈΡ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΡ ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»Π°
Π Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ° ΡΠΎΠ·Π΄Π°Π½ΠΈΡ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ Ρ ΠΈΠΌΠΈΠΊΠΎ-ΡΠ°ΡΠΌΠ°ΡΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈΠ½Π΄ΡΡΡΡΠΈΠΈ Π²ΡΠ΄Π²ΠΈΠ³Π°Π΅ΡΡΡ Π² ΡΡΠ΄ Π²Π°ΠΆΠ½Π΅ΠΉΡΠΈΡ ΡΠ»Π΅ΠΌΠ΅Π½ΡΠΎΠ² Π½Π°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΠΈ, Π° ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΡΠΈΠ½ΡΠ΅Π·Π° Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈ Π°ΠΊΡΠΈΠ²Π½ΡΡ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°Π΅ΡΡΡ ΠΊΠ°ΠΊ ΠΎΠ΄ΠΈΠ½ ΠΈΠ· ΠΊΠ»ΡΡΠ΅Π²ΡΡ ΡΡΠ°ΠΏΠΎΠ² Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ Π±Π°Π·ΠΎΠ²ΡΡ ΡΠ΅Ρ Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ ΡΡΠΎΠΉ ΠΈΠ½Π΄ΡΡΡΡΠΈΠΈ. Π ΡΠ²ΡΠ·ΠΈ Ρ ΡΡΠΈΠΌ, Π² ΠΎΠ±Π»Π°ΡΡΠΈ ΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Ρ ΠΈΠΌΠΈΠΈ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡΡ Π²ΡΠ΅ Π±ΠΎΠ»ΡΡΠ΅… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- 1. ΠΠΠ’ΠΠ ΠΠ’Π£Π ΠΠ«Π ΠΠΠΠΠ
- 1. 1. Π‘ΠΈΠ½ΡΠ΅Π· ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»ΠΎΠ² ΠΏΡΡΠ΅ΠΌ Π½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΡ Π³ΠΈΠ΄- 7 ΡΠΎΠΊΡΠΈΠ»Π°ΠΌΠΈΠ½Π° ΠΊ Π±ΠΈΠ½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ»ΡΠ½ΡΠΌ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΡΠΌ
- 1. 2. Π‘ΠΈΠ½ΡΠ΅Π· ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»ΠΎΠ² ΠΈΠ· Π½ΠΈΡΡΠΈΠ»ΠΎΠ² N-ΠΎΠΊΡΠΈΠ΄ΠΎΠ²
- 1. 3. ΠΡΡΠ³ΠΈΠ΅ ΡΠΏΠΎΡΠΎΠ±Ρ ΡΠΈΠ½ΡΠ΅Π·Π° ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»ΠΎΠ²
- 1. 4. ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΡ ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»Π°
- 2. Π₯ΠΠΠΠ§ΠΠ‘ΠΠΠ― Π§ΠΠ‘Π’
- 2. 1. Π€ΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΠΈΠ·Π°ΡΠΈΡ 3,5-Π΄ΠΈΠΌΠ΅ΡΠΈΠ»ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»Π° ΠΈ Π½ΠΎΠ²ΡΠ΅ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ 37 ΠΏΡΠ΅Π²ΡΠ°ΡΠ΅Π½ΠΈΠΉ Π΅Π³ΠΎ ΡΡΠ»ΡΡΠΎ- ΠΈ Π½ΠΈΡΡΠΎΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΡ
- 2. 1. 1. Π‘ΡΠ»ΡΡΠ°ΠΌΠΈΠ΄Π½ΡΠ΅ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΠ΅ 3,5-Π΄ΠΈΠΌΠ΅ΡΠΈΠ»ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»Π°
- 2. 1. 2. Π‘ΡΠ»ΡΡΠ°ΠΌΠΈΠ΄Π½ΡΠ΅ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΠ΅ Π-ΠΌΠ΅ΡΠΈΠ»-5-Π°ΠΌΠΈΠ½ΠΎΠ²ΠΈΠ½ΠΈΠ» Π·Π°ΠΌΠ΅- 40 ΡΠ΅Π½Π½ΡΡ ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»ΠΎΠ²
- 2. 1. 3. Π‘ΡΠ»ΡΡΠ°ΠΌΠΈΠ΄Π½ΡΠ΅ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΠ΅ Π-ΠΌΠ΅ΡΠΈΠ»-5-Π²ΠΈΠ½ΠΈΠ» Π·Π°ΠΌΠ΅ΡΠ΅Π½Π½ΡΡ 45 ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»ΠΎΠ²
- 2. 1. 4. Π‘ΡΠ»ΡΡΠ°ΠΌΠΈΠ΄Π½ΡΠ΅ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΠ΅ 3-ΠΌΠ΅ΡΠΈΠ»-4-Π½ΠΈΡΡΠΎ-5- 46 Π²ΠΈΠ½ΠΈΠ»ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»ΠΎΠ²
- 2. 2. Π‘ΠΈΠ½ΡΠ΅Π· Π΄Π²ΡΡΠ΄Π΅ΡΠ½ΡΡ
ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ, ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΡ
ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»ΡΠ½ΡΠΉ 49 ΡΠΈΠΊΠ», ΠΈΡ
ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΠΈΠ·Π°ΡΠΈΡ ΠΈ ΠΏΡΠ΅Π²ΡΠ°ΡΠ΅Π½ΠΈΡ
- 2. 2. 1. ΠΠ°ΠΌΠ΅ΡΠ΅Π½Π½ΡΠ΅ 5-Π°ΡΠΈΠ»- ΠΈ 5-Π³Π΅ΡΠ΅ΡΠΈΠ»ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»Ρ
- 2. 2. 2. ΠΠ°ΠΌΠ΅ΡΠ΅Π½Π½ΡΠ΅ 3-Π³Π΅ΡΠ΅ΡΠΈΠ»ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»Ρ
- 2. 2. 3. ΠΠ°ΠΌΠ΅ΡΠ΅Π½Π½ΡΠ΅ 4-Π°ΡΠΈΠ»ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»Ρ
- 2. 1. Π€ΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΠΈΠ·Π°ΡΠΈΡ 3,5-Π΄ΠΈΠΌΠ΅ΡΠΈΠ»ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»Π° ΠΈ Π½ΠΎΠ²ΡΠ΅ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ 37 ΠΏΡΠ΅Π²ΡΠ°ΡΠ΅Π½ΠΈΠΉ Π΅Π³ΠΎ ΡΡΠ»ΡΡΠΎ- ΠΈ Π½ΠΈΡΡΠΎΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΡ
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- Claisen L., LowmanO. //Ber. — 1888. -21. — p. 1149.
- Quilico A., Speroni G. // Gazz. Chim. Ital. 1946. — 78. — p. 148.
- Pavlik J.W., Lowell J.A., Vuthichai Ervithayasuporn Synthesys of 3-phenyl-5-(trifluoromethil)isoxazole and 5-phenyl-3-(trifluoromethil)isoxazole // J. Heterocyclic Chem. 2005. — 42. — p. 1253−1255
- Fossa P., Schenone P. 5-Substituted 4-isoxazolecarboxamides with platelet antiaggregating and other activities // Farmaco. 1991. — 46, № 6. — p. 789−802.
- S.A. Lang, Jr. Lin, Y.-i Lin Comprehensive Heterocycl. Chem., ed. A. R. Katritzky. Pergamon. — Oxford. — 1997. — vol. 6. — p. 1−130.
- Doorenbos N.J., Milewich L. 17^-Isoxazolyl and 17^-Pyrazolyl Steroids from 3— Hydroxy-21-formylpregn-5-en-20-one. Structural Assignments1'2 // J. Org. Chem. 1966.-31.-p. 3193−3199.
- Ling Y., Li J., Liu Y., et al.- 17-Imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives, novel steroidal inhibitors of human cytochrome Cj^o-lyase (P450i7a) // J. Med. Chem. 1997. 40, № 20. — p. 3297−3304.
- Lin Y.I., Lang S.A. Preparation of 4-(5-isoxazolyl)toluene // J. Org. Chem. 1980. -45.-p. 4857−4860.
- Manferdini M., Morelli C.F., Veronese A.C. Chemoselective synthesis of pyrazole derivatives via p-enamino keto esters // Heterocycles. 2000. — 53, № 12. — p. 2775−2780.
- Π’ΠΎΠ»ΠΌΠ°ΡΠ΅Π² Π.Π., ΠΠ°Π±ΠΈΡΠ΅Π½ΠΊΠΎ JI.H., Π¨Π΅ΠΉΠ½ΠΊΠΌΠ°Π½ Π. Π. Π‘ΠΈΠ½ΡΠ΅Π· 3,4-Π΄ΠΈΠ³ΠΈΠ΄ΡΠΎΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»ΠΎΠ² ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΡ Ρ-ΠΊΠ°ΡΠ±ΠΎΠ½ΠΈΠ»Π·Π°ΠΌΠ΅ΡΠ΅Π½Π½ΡΡ 1,3,3-ΡΡΠΈΠΌΠ΅ΡΠΈΠ»2.ΠΌΠ΅ΡΠΈΠ»Π΅Π½ΠΈΠ½Π΄ΠΎΠ»ΠΈΠ½ΠΎΠ² ΠΈ ΠΈΡ Ρ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠ΅Π²ΡΠ°ΡΠ΅Π½ΠΈΡ // Π₯ΠΠ‘. -1993. № 4. — Ρ. 523−528.
- Swedberg M.D.B., Olesen Π .Π. 3-(5-Alkylamino-4-isoxazolyl)-l, 2,5,6-tetrahydropyridines: A novel class of central nicotinic receptor ligands // Bioorg. Med. Chem. 1998. — 6, № 9. — p. 1623−1627.
- Π₯ΠΈΠ»Ρ Π.Π., ΠΡΠ΅Π½ΠΊΠΎ B.B. Π€Π»Π°Π²ΠΎΠ½Ρ, ΠΈΠ·ΠΎΡΠ»Π°Π²ΠΎΠ½Ρ, 2- ΠΈ 3-Π³Π΅ΡΠ°ΡΠΈΠ»Ρ ΡΠΎΠΌΠΎΠ½Ρ Π² ΡΠ΅Π°ΠΊΡΠΈΡΡ Ρ Π³ΠΈΠ΄ΡΠΎΠΊΡΠΈΠ»Π°ΠΌΠΈΠ½ΠΎΠΌ // Π₯ΠΠ‘. 2002. — 08. — Ρ. 1019−1037.
- Sorensen U.S., Falch Π., Stendbol Π’.Π., et al. Structural determinants for AMPA agonist activity of aryl or heteroaryl substituted AMPA analogues. Synthesis and pharmacology // Arch. Pharm. Pharm. Med. Chem. 2001.-334. — p. 62−68.
- Ruhland Π., Leclerc G. Synthesis of l-hydroxy-2H, 5H-dihydroisoxazolo5,4-c.quinoline. A novel heterocyclic ring system // J. Heterocyclic Chem. 1989. -26.-p. 469−471.
- Ikegami F., Yamamoto A., Sekine Π’., et al. Synthesis and pharmacological activity of 0-(5-isoxazolyl)-L-serine // Chem. Pharm. Bull. 2000. — 48, № 2. — p. 278 280.
- Iwai I., NakamuraN. // Chem. Pharm. Bull. 1966. — 14. — p. 1277−1281.
- Kochetkov N.K., Sokolov S.D. // Adv. Heterocycl. Chem. 1963. — 2. — p. 365 369.
- Purkayastha M.L., Ila H., Junjappa H. Regioselective synthesis of 5-alkylthio and3. alkylthioisoxazoles from acylketene dithioacetals // Synthesis. 1989. — p. 2024.
- Rahman A., Vishwakarma J.N., Yaday R.D., et al. Reaction of a-ketoketene S, N-acetals with hydroxylamine: a facile general route to 5-aryl-3-(N-arylamino, N-alkylamino, or N-azacycloalkyl) — isoxazoles // Synthesis, BRD. 1984. — p. 247 249.
- Ddannhardt Von Gerd, Obergrusberger Irmengard Untersuchungen zur darstellung von 5-(beta-aminoethyl)-thioisoxazolen // Chem.-ZTG. 1989. — 113. — p. 109 113.
- Balbi A., Ermili A. Reazone di 3-(dialchilammino)-lH-nafto<2,l-B>piran-l-oni con idrossilammina // Farmaco. Ed. Sci. 1982. — 37, № 6. — p. 387−397.
- ΠΠΎΡΠ΅ΡΠΊΠΎΠ² H.K., Π₯ΠΎΠΌΡΡΠΎΠ²Π° Π. Π. // ΠΠΠ₯. 1960. — 30. — p. 954−958.
- Popat K.H., Nimavat K.S. Synthesis and biological activity of 3-aryl-5-(3-bromo/chlorophenyl)isoxazoles // J. Indian Chem. Soc. 2003. — 80, № 7. — p. 707−708.
- Habeeb A.G., Praveen Rao N.P., Knaus E. E. Design and Synthesis of 4,5-Diphenyl-4-isoxazolines: Novel Inhibitors of Cyclooxygenase-2 with Analgesic and Antiinflammatory Activity // J. Med. Chem. 2001. — 44, № 18. — p. 29 212 927.
- Anjaneyulu A. S. R., Sudha Rani G. Synthesis and characterization of some new oxygen and nitrogen heterocyclics: Part II. 3,5-diarylisoxazoles, pyrazoles and 4,6-diarylpyrimidines // Indian J. Chem. B. 1995. — 34, № 11. — p. 933−938
- Albar Hassan A., Makki Mohamad S. I., Faidallah Hassan M. Synthesis of heterocyclic compounds from delta-unsaturated 1,3-diketo-esters // Indian J. Chem. B. -1996.-35, β l.-p. 23−29.
- Choji K., Nobuyoshi Y. Gezielte darstellung von unsymmetrischen isoxazolen aus enonen//Heterocycles.- 1981.- 16,β l.-p. 145−148.
- Kashima C., Shirai S. Regiospezifische synthese von isoxazolen durch reaktion von alpha-brom-enonen mit hidroxylamin // J. Chem. Soc. Chem. Commun. -1980.- 17.-p. 826−827.
- Quilico A. // Experientia. 1970. — 26. — p. 1169−1173.
- Kai H., Tomida M., Nakai Π’., et al. A convenient synthesis of 3-benzoylisoxazoles by 1,3-dipolar cycloaddition // Heterocycles. 2002. — 57, № 12. — p. 2299−2308.
- Simoni D., Invidiata F.P., Rondanin R., et al. Structure-activity relationship studies of novel heteroretinoids: induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid // J. Med. Chem. 1999. — 42. — p. 4961−4969.
- De Luca L., Giacomelli G., Riu A. Solid-phase synthesis of isoxazole-based amino acids: a new scaffold for molecular diversity // J. Org. Chem. 2001. — 66. — p. 6823−6825.
- Cereda E., Ezhaya A., Quai M. Solid-phase synthesis of 3-hydroxymethyl isoxa-zoles via resin bound nitrile oxides // Tetrahedron Lett. 2001. — 42. -p. 49 514 953.
- ΠΡΠΊΠ΅Π²ΠΈΡ Π., ΠΡΡΠ΅Π½ΡΠ½ Π. ΠΠ΅ΠΏΡΠ΅Π΄Π΅Π»ΡΠ½ΡΠ΅ Π³Π΅ΡΠΌΠ°Π½Ρ ΠΈ ΡΡΠ°Π½Π°Π½Ρ Π² ΡΠΈΠ½ΡΠ΅Π·Π΅ Π°Π·ΠΎΡΠΎΡΠΎ-Π΄Π΅ΡΠΆΠ°ΡΠΈΡ Π³Π΅ΡΠ΅ΡΠΎΡΠΈΠΊΠ»ΠΎΠ² ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ 2+3.-ΡΠΈΠΊΠ»ΠΎΠΏΡΠΈΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΡ // Π₯ΠΠ‘. 1998.- № 9. Ρ. 1155−1169.
- Hassner A., Dehaen W. Cycloadditions, 47. A route to fiinctionalized cyclic ethers by intramolecular cycloadditions of unsaturated nitro ethers // Chem. Ber. 1991. -Bd 124, № 5.-p. 1184−1187.
- Diamantini G., Duranti E., Tontini A. Nitroisoxazoles by manganese (IV) oxide oxidation of nitro-4,5-dihydroisoxazoles // Synthesis. 1993. — p. 1104−1108
- Jones R.C.F., Bhalay G., Carter P.A., et al. 1,3-Dipolar cycloaddition route to nitrogen heterocyclic triones // J. Chem. Soc., Perkin Trans. 1. 1999. — p. 765 776.
- Mosher M.D., Natale N.R. The preparation of intercalating isoxazoles via a nitrile oxide cicloaddition // J. Heterocycl. Chem. 1995. — 32. — p. 0779−0781.
- ΠΠ°Ρ Π²ΠΈΡ Π€.Π., ΠΠΎΡΠΎΠ»Π΅Π²Π° E.B. ΠΠΎΠ²ΡΠΉ ΠΏΠΎΠ΄Ρ ΠΎΠ΄ ΠΊ ΡΠΈΠ½ΡΠ΅Π·Ρ 16-Π³Π΅ΡΠ΅ΡΠΎΠΏΡΠΎΡΡΠ°Π½ΠΎΠΈΠ΄ΠΎΠ² ΡΠ΅ΡΠ΅Π· ΠΈΠ·ΠΎΠΊΡΠ°Π·ΠΎΠ»ΡΠ½ΡΠ΅ ΠΈΠ½ΡΠ΅ΡΠΌΠ΅Π΄ΠΈΠ°&trade- // Π₯ΠΠ‘. 1994. — № 3. — Ρ. 424.
- ΠΠ΅Π»Π΅Π½ΡΠΊΠΈΠΉ Π.Π. ΠΠΎΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΈ Π½ΠΎΠ²ΡΠ΅ ΠΏΡΠ΅Π²ΡΠ°ΡΠ΅Π½ΠΈΡ ΡΡΠΈΡ Π»ΠΎΡΠΌΠ΅ΡΠΈΠ»Π·Π°ΠΌΠ΅ΡΠ΅Π½Π½ΡΡ Π°Π»ΠΈΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ, Π°ΡΠΎΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈ Π³Π΅ΡΠ΅ΡΠΎΡΠΈΠΊΠ»ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΡΠ΄ΠΎΠ² // Π₯ΠΠ‘. 1993.- № 7. Ρ. 980−990.
- Tanaka K., Suzuki Π’., Maeno S., et al. Synyhesis and reaction of 5-amino-3-fluoromethylisoxazole and -pyrazole-4-carboxylic acids // J. Heterocyclic Chem. -1986.-23.-p. 1535−1538.
- Adhikari V.A., Badiger V.V. Heterocyclic systems containig bridgehead nitrogen atom: Synthesis and antimicrobial activities of isoxazolo4,5-e.imidazo/pyrimido[l, 2-c]pyrimidines // Indian J. Chem. 1991. — ΠΠΠ. — p. 946 949.
- A. Park. C.A., Beam C.F., Kaiser E.M., et al. Preparation of 2-isoxazolines from C (a), 0-dilithiooximes and aldehydes and ketones // J. Heterocyclic Chem. 1976. -13.-p. 449−453.
- Talley. J.J., Brown, D.L., Carter, J.S., et al. 4−5-Methyl-3-phenylisoxazol.4-yl]-benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2 // J. Med. Chem. 2000. — 43, № 5. — p. 775−777.
- Leeson P., Castacer J., Castacer R.M., et al. Valdecoxib and parecoxib sodium // Drugs Fut. 2001. — 26, № 2. — p. 133−135.
- Barber G.N., Olofson R.A. A useful, regiospecific synthesis of isoxazoles // J. Org. Chem. 1978. — 43, № 15. — p. 3015−3021.
- Alcantara M.-P.D., Escribano F.C., Gomes-Sanchez A., et al. Synthesis of aliphatic 1,3-dinitro compounds // Synthesis. 1996. — p. 64−70.
- Best W.M., Ghisalberti E.L., Powell M. Simple synthesis of symmetrical 4-substituted 3,5-dialkylisoxazoles // J. Chem. Research (S). 1998. — p. 388−389.
- Buron C., Kaim L. E., Uslu A. A new straightforward formation of aminoisoxazoles from isocyanides // Tetrahedron Lett. 1997. — 38. — p. 80 278 030.
- Pinho e Melo T.M.V.D., Lopes C. S J., Rocha Gonsalves A. M. d’A., et al. Reactivity of 2-halo-2H-azirines. Part II. Thermal ring expansion reactions: synthesis of 4-haloisoxazoles // Synthesis. 2002. — 5. — p. 605−608.
- Padwa A., Smolanoff J., Tremper A. Photochemical transformations of small ring heterocyclic systems. LXV. Intramolecular cycloaddition reactions of vinyl-substituted 2H-azirines // J. Am. Chem. Soc. 1975. — 97, № 16. — p. 4682−4685.
- ΠΠ΅ΡΠΈΡΠΎΠ²Π° O.H., ΠΠ΅ΡΠΈΡΠΎΠ² H.C. ΠΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠ°Ρ Ρ ΠΈΠΌΠΈΡ (Medicinal chemistry). 2. ΠΠ΅ΡΠΎΠ΄ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΡΠ½ΠΎΠ²Ρ ΡΠΎΠ·Π΄Π°Π½ΠΈΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² // ΠΠ΅ΡΡΠ½. ΠΠΎΡΠΊ. ΡΠ½-ΡΠ°. Π‘Π΅Ρ.2. Π₯ΠΈΠΌΠΈΡ. Π’. 41., № 2.
- Leeson P., Castacer J., Castacer R.M., et.al. Valdecoxib and parecoxib sodium // Drugs Fut.- 2001.-26, № 2.-p. 133−135.
- Leeson P.A., Castacer J., Graul A. Sitaxsentan Sodium // Drugs Fut. 2000. — 25, № 2.-p. 159−161.
- Lombardino J.G., Wiseman E.H. Antiinflammatory 3,4-dihydro-2-alkyl-3-oxo-2H-l, 2-benzothiazine-4-carboxamide 1,1-dioxides // J. Med. Chem. -1971. 14, № 10.-p. 973−978.
- Pop Emil, Wu Whei-Mei, Bodor Nicholas Chemical delivery systems for some penicillinase-resistant demisynthetic penicillins // J. Med. Chem. 1989. — 32, № 8.-p. 1789−1795.
- Prous J., Castacer J. N-22 // Drugs Fut. 1988. — 13, № 12, — p. 1050−1055.
- ΠΠ²Π°Π½ΡΠΊΠΈΠΉ Π. Π. Π₯ΠΈΠΌΠΈΡ Π³Π΅ΡΠ΅ΡΠΎΡΠΈΠΊΠ»ΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ. Π.: ΠΡΡΡΠ°Ρ ΡΠΊΠΎΠ»Π°, 1978.
- Huang W.-H., Yang C.-L., Lee A.-R., et al. Leflunomide analogues as potential antiinflammatory agents // Chem. Pharm. Bull. 2003. — 51, № 3. — p. 313−314.
- Abdulla R.F., Brinkmeyer R.S. The chemistry of formamide acetals // Tetrahedron Report Number 67.- 1979.-35, № 14,-p. 1675−1735.
- Bostrom L.L., Knabb R.M., Wong P.C., et al. Isoxazolines and isoxazoles as factor Xa inhibitors // Bioorg. Med. Chem. Lett. 2000. — 10, № 8. — p. 685−688.
- Simoni D., et al.- Heterocycle-containing retinoids. Discovery of a novel isoxazole arotinoid possessing potent apoptotic activity in multidrug and drug-induced apop-tosis-resistant cells // J. Med. Chem. 2001. — 44, № 14. — p. 2308−2310.
- Breitmaier E. Structure elucidation by NMR in organic chemistry: a practical guide. John Wiley and Sons, 2002. — p. 1−258.
- Π₯Π°ΡΡΡΠ΅Ρ K.X., ΠΠ°Π»ΡΠ±ΠΈΡΡΠ΅Ρ X.P. Π―ΠΠ Π² ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Π΅ ΠΈ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ: ΡΡΡΡΠΊΡΡΡΠ° ΠΌΠΎΠ»Π΅ΠΊΡΠ», ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΡ ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΊΠΎΠΏΠΈΡ in-vivo. ΠΠΈΠ΅Π²: ΠΠ°ΡΠΊ. Π΄ΡΠΌΠΊΠ°, 1993. — 259 Ρ.
- ΠΠ΅Π±Π΅Π΄Π΅Π² Π.Π’. ΠΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡ Π² ΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Ρ ΠΈΠΌΠΈΠΈ. Π.: ΠΠΠΠΠ. ΠΠ°Π±ΠΎΡΠ°ΡΠΎΡΠΈΡ Π·Π½Π°Π½ΠΈΠΉ, 2003. — 493 Ρ.
- ΠΠΎΡΠ°ΠΉ-ΠΠΎΡΠΈΡ Π. Π. ΠΡΠ½ΠΎΠ²Ρ ΡΡΡΡΠΊΡΡΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° Ρ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ: ΡΡΠ΅Π±Π½ΠΎΠ΅ ΠΏΠΎΡΠΎΠ±ΠΈΠ΅. Π.: ΠΡΡΡΠ°Ρ ΡΠΊΠΎΠ»Π°, 1989. — 192 Ρ.
- ΠΠ°ΠΊΠ°Π½ΠΈΡΠΈ Π. ΠΠ½ΡΡΠ°ΠΊΡΠ°ΡΠ½ΡΠ΅ ΡΠΏΠ΅ΠΊΡΡΡ ΠΈ ΡΡΡΠΎΠ΅Π½ΠΈΠ΅ ΠΎΡΠ³Π°Π½ΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ. -Π.:ΠΠΈΡ, 1965.-231 Ρ.